PRegnancy Outcomes after a Maternity Intervention for Stressful EmotionS (PROMISES): study protocol for a randomised controlled trial

<p>Abstract</p> <p>Background</p> <p>There is ample evidence from observational prospective studies that maternal depression or anxiety during pregnancy is a risk factor for adverse psychosocial outcomes in the offspring. However, to date no previous study has demonstrated that treatment of depressive or anxious symptoms in pregnancy actually could prevent psychosocial problems in children. Preventing psychosocial problems in children will eventually bring down the huge public health burden of mental disease. The main objective of this study is to assess the effects of cognitive behavioural therapy in pregnant women with symptoms of anxiety or depression on the child's development as well as behavioural and emotional problems. In addition, we aim to study its effects on the child's development, maternal mental health, and neonatal outcomes, as well as the cost-effectiveness of cognitive behavioural therapy relative to usual care.</p> <p>Methods/design</p> <p>We will include 300 women with at least moderate levels of anxiety or depression at the end of the first trimester of pregnancy. By including 300 women we will be able to demonstrate effect sizes of 0.35 or over on the total problems scale of the child behavioural checklist 1.5-5 with alpha 5% and power (1-beta) 80%.</p> <p>Women in the intervention arm are offered 10-14 individual cognitive behavioural therapy sessions, 6-10 sessions during pregnancy and 4-8 sessions after delivery (once a week). Women in the control group receive care as usual.</p> <p>Primary outcome is behavioural/emotional problems at 1.5 years of age as assessed by the total problems scale of the child behaviour checklist 1.5 - 5 years.</p> <p>Secondary outcomes will be mental, psychomotor and behavioural development of the child at age 18 months according to the Bayley scales, maternal anxiety and depression during pregnancy and postpartum, and neonatal outcomes such as birth weight, gestational age and Apgar score, health care consumption and general health status (economic evaluation).</p> <p>Trial Registration</p> <p>Netherlands Trial Register (NTR): <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2242">NTR2242</a></p

T is associated with severe dyspepsia

Contains fulltext : 96333.pdf (publisher's version ) (Open Access

Carcass characteristics and meat quality of Hereford sired steers born to beef-cross-dairy and Angus breeding cows

Publishe

Hawthorn (Crataegus Oxyacantha) Extract in the Drinking Water of Broilers on Growth and Incidence of Pulmonary Hypertension Syndrome (PHS)

<div><p>ABSTRACT Hawthorn extract has been used for ameliorating cardiac disorders and pulmonary hypertension. Flavonoids and oligomeric proanthocyanidins are considered to be responsible for the positive health effects of hawthorn extract. The effect of Hawthorn extract in the water supply on feed intake, growth, carcass traits, internal organ weight, cardiac indices, the concentration of serum proteins and the incidence of pulmonary hypertension syndrome was evaluated in broiler chickens. At one day-of-age, 225 chickens were assigned to one of three experimental groups where 0, 0.1 and 0.2 ML of hawthorn extract was added per one liter of drinking water. Feed intake, live weight gain and carcass weight increased when hawthorn extract was included in the drinking water at a level of 0.1 and 0.2 ML/L (p<0.05). Compared to no extract, the addition of Hawthorn extract in the drinking water (p<0.05) reduced the proportion of the body attributed to abdominal fat, liver and heart (p<0.05), and decreased the percentage of birds that died or showed clinical symptoms of pulmonary hypertension syndrome (p<0.05). Serum protein concentration was (p<0.05) higher in chickens that received the hawthorn extract in the drinking water compared to no addition of extract in the drinking water. Hawthorn extract has shown potential for use as a herbal medicine to aid in the prevention of physiological cardiac disorders and pulmonary hypertension in chickens.</p></div

The current state of the New Zealand goat industry

Goat farming in New Zealand has a lower profile compared to dairy, sheep and beef systems. The goat industry is small in New Zealand (Stafford & Prosser, 2016) and there has been limited consideration of the potential for the industry to expand (Shepard & O’Donnell, 1979). The environmental and commodity market constraints currently impacting pastoral systems in New Zealand provide an opportunity for the goat industry to have a greater economic contribution to New Zealand’s agricultural production. In New Zealand, goats are farmed for milk, meat and fibre production and also act as a mechanism for controlling excess pasture growth, enhancing clover in mixed pasture and controlling weeds (Batten, 2014). The aim of this paper was to present an overview of the goat industry to provide background knowledge for consideration when deciding the direction of the goat industries in New Zealand. As part of the overview, farmers, processors and industry bodies were contacted to obtain an estimate of the number and location of goats farmed in New Zealand. Although some of the sources of information for the goat industry are not perfect, this research is an attempt to bring together information that has not been consolidated in nearly 40 years (Shepard & O’Donnell, 1979) and was achieved as part of a three-part study with companion papers being produced (Lopez-Lozano et al. 2017; Smith et al. 2017). Information from this study were used in conjunction with the value of the goat industry (Lopez-Lozano et al. 2017) to project the potential of the New Zealand goat industry (Smith et al. 2017).fals

Equity-specific effects of 26 Dutch obesity-related lifestyle interventions

Context: Reducing health inequalities is a policy priority in many developed countries. Little is known about effective strategies to reduce inequalities in obesity and its underlying behaviors. The goal of the study was to investigate differential effectiveness of interventions aimed at obesity prevention, the promotion of physical activity or a healthy diet by SES. Evidence acquisition: Subgroup analyses in 2010 and 2011 of 26 Dutch studies funded by The Netherlands Organization for Health Research and Development after 1990 (n=17) or identified by expert contact (n=9). Methodologic quality and differential effects were synthesized in harvest plots, subdivided by setting, age group, intensity, and time to follow-up. Evidence synthesis: Seven lifestyle interventions were rated more effective and four less effective in groups with high SES; for 15 studies no differential effects could be demonstrated. One study in the healthcare setting showed comparable effects in both socioeconomic groups. The only mass media campaign provided modest evidence for higher effectiveness among those with high SES. Individually tailored and workplace interventions were either more effective in higher-SES groups (n=4) or no differential effects were demonstrated (n=9). School-based studies (n=7) showed mixed results. Two of six community studies provided evidence for better effectiveness in lower-SES groups; none were more effective in higher-SES groups. One high-intensity community-based study provided best evidence for higher effectiveness in low-SES groups. Conclusions: Although for the majority of interventions aimed at obesity prevention, the promotion of physical activity, or a healthy diet, no differential effectiveness could be demonstrated, interventions may widen as well as reduce socioeconomic inequalities in these outcomes. Equity-specific subgroup analyses contribute to needed knowledge about what may work to reduce socioeconomic inequalities in obesity and underlying health behaviors. © 2013 American Journal of Preventive Medicine